Pot Stocks Post Roll: Weed Beta (VLNS), Growers vs. Suppliers (GRWG), MedMen (MMEN)


In this week’s edition of the Post Roll Thomas George and Scott Willis survey the coronavirus market carnage!

They examine the market beta of cannabis stocks and Valens (TSXV: VLNS) in particular.

Where’s the value? Growers or Suppliers – shedding light on two under-followed suppliers: GrowGeneration (NASDAQ: GRWG) – & Scotts Miracle Grow (NYSE: SMG).

Lastly Scott outlines the shaky financials of MedMen (CNSX: MMEN).

The opinions provided in this article are those of the author and do not constitute investment advice. Readers should assume that the author and/or employees of Grizzle hold positions in the company or companies mentioned in the article. For more information, please see our Content Disclaimer.

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Post


The Post Roll: Value Case for Trulieve (TRUL) & Toxic Pot Stocks

Scott Willis and Thomas George take stock of the battered down cannabis sector, even though sales have picked up during the coronavirus crisis the stocks have continued to trade like


Aphria Demonstrates Early Cannabis 2.0 Success with Q3 Revenue Beat

Canadian licensed producer Aphria (NYSE:APHA, TSE:APHA) announced a surprise beat today with revenue of C$144 million beating consensus by a whopping 25%. However, results below the line disappointed with EBITDA


OrganiGram’s Q2 2020 Earnings Show a Company Running Out of Cash

Organigram Holdings (TSE:OGI, NASDAQ:OGI) posted disappointing financial results for Q2 2020. More important than earnings is the company’s rapidly deteriorating financial position which is a surprise for what was once

Share via
Copy link
Powered by Social Snap